About Pr3vent
Pr3vent is a company based in San Francisco (United States) founded in 2017. Pr3vent has raised $2.5 million across 2 funding rounds from investors including InFocus Capital Partners, Trousdale Ventures and Skyview Ventures. Pr3vent offers products and services including Advanced Newborn Eye Screening. Pr3vent operates in a competitive market with competitors including Forus Health, Remidio, Optomed, Heru and Identifeye Health, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.5 M (USD)
in 2 rounds
-
Latest Funding Round
$1.5 M (USD), Series A
Feb 12, 2019
-
Investors
InFocus Capital Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pr3vent
Pr3vent offers a comprehensive portfolio of products and services, including Advanced Newborn Eye Screening.
Detects eye diseases in newborns via retinal imaging for early intervention.
People of Pr3vent
Unlock access to complete
Unlock access to complete
Funding Insights of Pr3vent
Pr3vent has successfully raised a total of $2.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.5 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pr3vent
Pr3vent has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include InFocus Capital Partners, Trousdale Ventures and Skyview Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment opportunities in ophthalmic innovations are managed by InFocus.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Pr3vent
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pr3vent
Investment portfolio details for Pr3vent
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pr3vent
Detailed financials for Pr3vent
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pr3vent Comparisons
Peer comparison for Pr3vent
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pr3vent
Pr3vent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Forus Health, Remidio, Optomed, Heru and Identifeye Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
|
|
| Locked | Locked | Locked |
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
|
|
| Locked | Locked | Locked |
Provider of handheld fundus cameras and software solutions for eye screening
|
|
| Locked | Locked | Locked |
AI-based wearable devices for vision disorder diagnostics are provided.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive test to detect health conditions through the eyes
|
|
| Locked | Locked | Locked |
Cloud-based vision testing software is offered for the optical industry.
|
Detailed competitors of Pr3vent
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pr3vent
Complete news archive for Pr3vent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pr3vent
Pr3vent was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Pr3vent is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Pr3vent is a funded company, having raised a total of $2.5M across 2 funding rounds to date.
Founded in 2017 and based in San Francisco, United States, Pr3vent operates in the health technology sector. An AI-driven platform is developed for detecting ophthalmic conditions in newborns through patented algorithms. Screening services are provided to support early identification of eye issues, with applications focused on neonatal care. Operations emphasize integration of technology into medical screening processes.
Pr3vent's top competitors include Remidio, Forus Health and Identifeye Health.
Pr3vent offers Advanced Newborn Eye Screening.
Pr3vent has 3 investors. Key investors include InFocus Capital Partners, Trousdale Ventures, and Skyview Ventures.